Aydin Dogan, PhD
Germany
CEO and Chief Scientist of Adoderm
Dr. Aydin Dogan has finished the Faculty of Chemistry of University Cologne-Germany and has started in 1984 his carrier as a Product Manager and scientific Product Development for 10 years with an American company. Since 1994, he established his own business under name of NOVAMEDICAL in Germany for developing and manufacturing of breast implants, dermal fillers and wound healing/ care products with patented licenses and formulation.
First injectable dermal filler was established and marketed in 1989.
Breast implant on hydrogel basis was developed in 1994.
The next injectable semi-permanent dermal filler was developed in 1999 on synthetic particles and hyaluronic acid as carrier agent.
Since October 2005, he established further ADODERM Company to be active especially in the field of Aesthetic - Dermatology and Cosmetic Medicine and Plastic Surgery.
The first developments in the field of Aesthetic - Dermatology and Cosmetic Medicine are topical Anti-Aging Product “NOVATOX®” and topical Anti-Cellulite-System “NOVAFORM®”. Within the new development of a trans-dermal delivery device of MPS-Microporation System Adoderm has established a new area of applications in the treatment of superficial skin.
In 2006, the first Varioderm dermal filler based on cross-linked hyaluronic acid launched into market.
Within next 3-4 years, Adoderm has developed more products for superficial and deep wrinkles, as well as volumizing products and became a top ten company in the field of aesthetic dermatology.
In 2010, based on the market demands a body-contouring product “Variofill” brought to the market.
Newest approach of ADODERM is the development of cross-linked hyaluronic acid dermal fillers with Lidocain, in various formulations for Dermal and Subdermal indications like filling and correction of wrinkles and contouring the face. With Hyabell Derma-Filler-Line ADODERM has increased its flagship products and is fulfilling the various demands of the doctors and the expectations of the patients.
ADODERM represents the innovation and development of various dermal fillers and breast, body and face implants for aesthetic and plastic surgery. With more than 30 years of ongoing research and development, the team of ADODERM has introduced numerous and patented products into the medical device market and has achieved a worldwide distribution in more than 60 countries.
First injectable dermal filler was established and marketed in 1989.
Breast implant on hydrogel basis was developed in 1994.
The next injectable semi-permanent dermal filler was developed in 1999 on synthetic particles and hyaluronic acid as carrier agent.
Since October 2005, he established further ADODERM Company to be active especially in the field of Aesthetic - Dermatology and Cosmetic Medicine and Plastic Surgery.
The first developments in the field of Aesthetic - Dermatology and Cosmetic Medicine are topical Anti-Aging Product “NOVATOX®” and topical Anti-Cellulite-System “NOVAFORM®”. Within the new development of a trans-dermal delivery device of MPS-Microporation System Adoderm has established a new area of applications in the treatment of superficial skin.
In 2006, the first Varioderm dermal filler based on cross-linked hyaluronic acid launched into market.
Within next 3-4 years, Adoderm has developed more products for superficial and deep wrinkles, as well as volumizing products and became a top ten company in the field of aesthetic dermatology.
In 2010, based on the market demands a body-contouring product “Variofill” brought to the market.
Newest approach of ADODERM is the development of cross-linked hyaluronic acid dermal fillers with Lidocain, in various formulations for Dermal and Subdermal indications like filling and correction of wrinkles and contouring the face. With Hyabell Derma-Filler-Line ADODERM has increased its flagship products and is fulfilling the various demands of the doctors and the expectations of the patients.
ADODERM represents the innovation and development of various dermal fillers and breast, body and face implants for aesthetic and plastic surgery. With more than 30 years of ongoing research and development, the team of ADODERM has introduced numerous and patented products into the medical device market and has achieved a worldwide distribution in more than 60 countries.